Tristel (TSTL) - Total Liabilities
Based on the latest financial reports, Tristel (TSTL) has total liabilities worth GBX11.88 Million GBX (≈ $1.45K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TSTL long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Tristel - Total Liabilities Trend (2003–2025)
This chart illustrates how Tristel's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see TSTL total asset value.
Tristel Competitors by Total Liabilities
The table below lists competitors of Tristel ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Begbies Traynor Group PLC
LSE:BEG
|
UK | GBX83.60 Million |
|
Thai Setakij Insurance PCL
BK:TSI
|
Thailand | ฿949.34 Million |
|
Elong Power Holding Limited Class A Ordinary Shares
NASDAQ:ELPW
|
USA | $50.49 Million |
|
Vast Renewables Limited Ordinary Shares
NASDAQ:VSTE
|
USA | $24.07 Million |
|
Global Battery Metals Ltd
V:GBML
|
Canada | CA$1.03 Million |
|
Invion Ltd
AU:IVX
|
Australia | AU$1.24 Million |
|
Discovery Alaska Ltd
AU:DAF
|
Australia | AU$74.02K |
Liability Composition Analysis (2003–2025)
This chart breaks down Tristel's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Tristel to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tristel's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tristel (2003–2025)
The table below shows the annual total liabilities of Tristel from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | GBX12.34 Million ≈ $1.50K |
+5.50% |
| 2024-06-30 | GBX11.70 Million ≈ $1.42K |
+9.51% |
| 2023-06-30 | GBX10.68 Million ≈ $1.30K |
+9.54% |
| 2022-06-30 | GBX9.75 Million ≈ $1.19K |
-0.96% |
| 2021-06-30 | GBX9.85 Million ≈ $1.20K |
-21.03% |
| 2020-06-30 | GBX12.47 Million ≈ $1.52K |
+142.91% |
| 2019-06-30 | GBX5.13 Million ≈ $624.66 |
+24.82% |
| 2018-06-30 | GBX4.11 Million ≈ $500.43 |
+1.56% |
| 2017-06-30 | GBX4.05 Million ≈ $492.77 |
+5.91% |
| 2016-06-30 | GBX3.82 Million ≈ $465.27 |
+34.27% |
| 2015-06-30 | GBX2.85 Million ≈ $346.52 |
-5.22% |
| 2014-06-30 | GBX3.00 Million ≈ $365.62 |
+60.61% |
| 2013-06-30 | GBX1.87 Million ≈ $227.65 |
-19.70% |
| 2012-06-30 | GBX2.33 Million ≈ $283.49 |
+16.79% |
| 2011-06-30 | GBX2.00 Million ≈ $242.73 |
-42.19% |
| 2010-06-30 | GBX3.45 Million ≈ $419.89 |
+97.43% |
| 2009-06-30 | GBX1.75 Million ≈ $212.68 |
+21.39% |
| 2008-06-30 | GBX1.44 Million ≈ $175.21 |
-29.62% |
| 2007-06-30 | GBX2.05 Million ≈ $248.94 |
+46.14% |
| 2006-06-30 | GBX1.40 Million ≈ $170.34 |
+15.61% |
| 2005-06-30 | GBX1.21 Million ≈ $147.34 |
+18.03% |
| 2004-04-30 | GBX1.03 Million ≈ $124.83 |
0.00% |
| 2003-06-30 | GBX1.03 Million ≈ $124.83 |
-- |
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more